• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测接受根治性膀胱切除术的可切除膀胱尿路上皮癌患者预后的列线图的开发与验证:一项多中心回顾性研究

Development and validation of nomograms for predicting prognosis in patients with resectable bladder urothelial carcinoma undergoing radical cystectomy: a multicenter retrospective study.

作者信息

Ji Junjie, Wen Zengjin, Yao Yu, Jiang Lei, Yang Qingya, Zhang Guiming

机构信息

Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, China.

School of Rehabilitation, Capital Medical University, Beijing, China.

出版信息

Front Oncol. 2025 Jul 3;15:1571604. doi: 10.3389/fonc.2025.1571604. eCollection 2025.

DOI:10.3389/fonc.2025.1571604
PMID:40678059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12268282/
Abstract

PURPOSE

This study aimed to construct and validate nomograms for the prediction of overall survival (OS), cancer-specific survival (CSS), and disease-free survival (DFS) in patients with resectable bladder urothelial carcinoma (BUC) after radical cystectomy (RC).

METHODS

We retrospectively collected the demographic, pathological, imaging, and laboratory data from patients with BUC who underwent RC. The training cohort included patients from the Affiliated Hospital of Qingdao University from January 2018 to December 2021, while the test cohort included patients from the same hospital between January 2016 and December 2017, along with patients from Qilu Hospital of Shandong University. Univariate and multivariate Cox regression analyses were conducted to identify independent predictors of OS, CSS, and DFS. The performance of the nomograms was evaluated using Harrell's concordance index (-index), the area under the receiver operating characteristic (ROC) curve (AUC), the corrected AUC following 1,000 bootstrap resamplings with calibration curves, and decision curve analysis in both cohort validations.

RESULTS

A total of 393 patients were included in the training cohort, while 156 patients comprised the test cohort. Multivariate analyses revealed that age, tumor size, lymph node metastasis (LNM), lymphovascular invasion (LVI), urea nitrogen, creatinine, and the albumin/fibrinogen ratio (AFR) were independent predictors for OS. For CSS, the independent predictors were tumor size, LNM, LVI, urea nitrogen, and AFR. LNM and LVI were the independent predictors for DFS. The nomograms for OS and CSS demonstrated high predictive accuracy with robust C-indexes and ROC curves, along with reliable calibration curves with corrected AUCs and clinical utility in both cohorts. The DFS nomogram also showed high predictive accuracy with stable corrected AUCs in both cohorts.

CONCLUSION

We constructed OS, CSS, and DFS nomograms to predict prognosis in patients with BUC treated with RC. These nomograms exhibited high accuracy, reliability, and clinical utility in predicting outcomes in both cohorts.

摘要

目的

本研究旨在构建并验证列线图,用于预测根治性膀胱切除术后可切除膀胱尿路上皮癌(BUC)患者的总生存期(OS)、癌症特异性生存期(CSS)和无病生存期(DFS)。

方法

我们回顾性收集了接受根治性膀胱切除术的BUC患者的人口统计学、病理学、影像学和实验室数据。训练队列包括2018年1月至2021年12月期间青岛大学附属医院的患者,而测试队列包括2016年1月至2017年12月期间同一家医院的患者以及山东大学齐鲁医院的患者。进行单因素和多因素Cox回归分析,以确定OS、CSS和DFS的独立预测因素。使用Harrell一致性指数(C指数)、受试者操作特征(ROC)曲线下面积(AUC)、1000次自举重采样后校正的AUC以及校准曲线在两个队列验证中的决策曲线分析来评估列线图的性能。

结果

训练队列共纳入393例患者,测试队列共156例患者。多因素分析显示,年龄、肿瘤大小、淋巴结转移(LNM)、淋巴管侵犯(LVI)、尿素氮、肌酐和白蛋白/纤维蛋白原比值(AFR)是OS的独立预测因素。对于CSS,独立预测因素为肿瘤大小、LNM、LVI、尿素氮和AFR。LNM和LVI是DFS的独立预测因素。OS和CSS的列线图显示出较高的预测准确性,具有稳健的C指数和ROC曲线,以及两个队列中具有校正AUC的可靠校准曲线和临床实用性。DFS列线图在两个队列中也显示出较高的预测准确性,校正后的AUC稳定。

结论

我们构建了OS、CSS和DFS列线图,以预测接受根治性膀胱切除术治疗的BUC患者的预后。这些列线图在预测两个队列的结果方面表现出较高的准确性、可靠性和临床实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cc/12268282/d1791c4c9a0d/fonc-15-1571604-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cc/12268282/03b4b67dc820/fonc-15-1571604-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cc/12268282/b7fe3b5eb8de/fonc-15-1571604-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cc/12268282/0eb13bd1c071/fonc-15-1571604-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cc/12268282/a7faa3d33386/fonc-15-1571604-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cc/12268282/c5f5c77d25f3/fonc-15-1571604-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cc/12268282/d1791c4c9a0d/fonc-15-1571604-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cc/12268282/03b4b67dc820/fonc-15-1571604-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cc/12268282/b7fe3b5eb8de/fonc-15-1571604-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cc/12268282/0eb13bd1c071/fonc-15-1571604-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cc/12268282/a7faa3d33386/fonc-15-1571604-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cc/12268282/c5f5c77d25f3/fonc-15-1571604-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cc/12268282/d1791c4c9a0d/fonc-15-1571604-g006.jpg

相似文献

1
Development and validation of nomograms for predicting prognosis in patients with resectable bladder urothelial carcinoma undergoing radical cystectomy: a multicenter retrospective study.预测接受根治性膀胱切除术的可切除膀胱尿路上皮癌患者预后的列线图的开发与验证:一项多中心回顾性研究
Front Oncol. 2025 Jul 3;15:1571604. doi: 10.3389/fonc.2025.1571604. eCollection 2025.
2
Development and validation of nomograms for predicting survival of locally advanced rectosigmoid junction cancer patients: a SEER database analysis.预测局部晚期直肠乙状结肠交界处癌患者生存的列线图的开发与验证:一项监测、流行病学和最终结果(SEER)数据库分析
Transl Cancer Res. 2025 May 30;14(5):2808-2821. doi: 10.21037/tcr-24-1810. Epub 2025 May 27.
3
A prognostic nomogram utilized lymph node ratio for signet ring cell gastric cancer patients post-surgery.一种预后列线图利用淋巴结比值用于胃印戒细胞癌患者术后。
J Gastrointest Oncol. 2025 Jun 30;16(3):950-964. doi: 10.21037/jgo-24-745. Epub 2025 Jun 18.
4
Nomogram for the prediction of the prognosis of patients with triple-negative invasive ductal carcinoma of breast after neoadjuvant chemotherapy.用于预测三阴性浸润性乳腺癌患者新辅助化疗后预后的列线图。
Sci Rep. 2025 Jul 1;15(1):21666. doi: 10.1038/s41598-025-05738-y.
5
Prognostic value of blood lipids on patients treated with oxaliplatin combined with S-1 (SOX) after radical gastrectomy and establishment of prognostic nomogram.奥沙利铂联合替吉奥(SOX)方案根治性胃切除术后血脂对患者预后的价值及预后列线图的建立。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10293-10305. doi: 10.1007/s00432-023-04942-5. Epub 2023 Jun 4.
6
Dynamic nomogram for predicting the overall survival and cancer-specific survival of patients with gastrointestinal neuroendocrine tumor: a SEER-based retrospective cohort study and external validation.预测胃肠道神经内分泌肿瘤患者总生存期和癌症特异性生存期的动态列线图:一项基于监测、流行病学和最终结果(SEER)数据库的回顾性队列研究及外部验证
Front Oncol. 2025 Jun 4;15:1594591. doi: 10.3389/fonc.2025.1594591. eCollection 2025.
7
Comprehensive study of clinical features, prognostic factors, and survival in patients with pancreatic solid pseudopapillary neoplasms based on the 2019 WHO classification.基于 2019 年 WHO 分类的胰腺实性假乳头状瘤患者临床特征、预后因素和生存的综合研究。
J Cancer Res Clin Oncol. 2023 Oct;149(13):12393-12404. doi: 10.1007/s00432-023-04982-x. Epub 2023 Jul 13.
8
Two web-based dynamically interactive nomograms and risk stratification systems for predicting survival outcomes and guiding treatment in non-metastatic nasopharyngeal carcinoma.用于预测非转移性鼻咽癌生存结局并指导治疗的两个基于网络的动态交互式列线图和风险分层系统。
J Cancer Res Clin Oncol. 2023 Nov;149(17):15969-15987. doi: 10.1007/s00432-023-05363-0. Epub 2023 Sep 8.
9
Prediction of death probability in adenocarcinoma of the transverse colon: competing-risk nomograms based on 21,469 patients.横结肠癌死亡概率的预测:基于21469例患者的竞争风险列线图
J Cancer Res Clin Oncol. 2023 Sep;149(12):10435-10452. doi: 10.1007/s00432-023-04913-w. Epub 2023 Jun 6.
10
Development and validation of a prognostic nomogram for gastric GIST patients under 65 years of age.65岁以下胃间质瘤患者预后列线图的开发与验证
Discov Oncol. 2025 Jul 11;16(1):1313. doi: 10.1007/s12672-025-03092-z.

本文引用的文献

1
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024.NCCN 指南®洞察:膀胱癌,第 3.2024 版。
J Natl Compr Canc Netw. 2024 May;22(4):216-225. doi: 10.6004/jnccn.2024.0024.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
The impact of perioperative risk factors on long-term survival after radical cystectomy: a prospective, high-volume cohort study.
围手术期风险因素对根治性膀胱切除术长期生存的影响:一项前瞻性、大容量队列研究。
World J Urol. 2024 Mar 15;42(1):164. doi: 10.1007/s00345-024-04887-5.
4
Advances in diagnosis and treatment of bladder cancer.膀胱癌的诊断与治疗进展。
BMJ. 2024 Feb 12;384:e076743. doi: 10.1136/bmj-2023-076743.
5
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
6
A novel nomogram based on body composition and nutritional indicators to predict the prognosis of patients with muscle-invasive bladder cancer undergoing radical cystectomy.一种基于身体成分和营养指标的新型列线图,用于预测接受根治性膀胱切除术的肌肉浸润性膀胱癌患者的预后。
Cancer Med. 2023 Dec;12(24):21627-21638. doi: 10.1002/cam4.6712. Epub 2023 Nov 16.
7
Assessing the prognostic impact of prostatic urethra involvement and developing a nomogram for T1 stage bladder cancer.评估前列腺尿道受累对 T1 期膀胱癌预后的影响并建立列线图。
BMC Urol. 2023 Nov 10;23(1):182. doi: 10.1186/s12894-023-01342-2.
8
Bladder cancer.膀胱癌。
Nat Rev Dis Primers. 2023 Oct 26;9(1):58. doi: 10.1038/s41572-023-00468-9.
9
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines.欧洲泌尿外科学会肌层浸润性和转移性膀胱癌指南:2023 年指南摘要。
Eur Urol. 2024 Jan;85(1):17-31. doi: 10.1016/j.eururo.2023.08.016. Epub 2023 Oct 17.
10
Survival nomogram for high-grade bladder cancer patients after surgery based on the SEER database and external validation cohort.基于监测、流行病学和最终结果(SEER)数据库及外部验证队列的高级别膀胱癌患者术后生存列线图。
Front Oncol. 2023 Jun 16;13:1164401. doi: 10.3389/fonc.2023.1164401. eCollection 2023.